Marengo Therapeutics Enters Multi-Year Collaboration With University of Pennsylvania Institute for Immunology and Immune Health to Advance Next Wave Precision T Cell Immunology Research in Oncology and Autoimmune Diseases

Collaboration focuses on deeper exploration of Marengo’s selective dual T cell agonists in oncology, and expansion of precision T cell depleting platform across a range of autoimmune diseases Partnership with world-renowned T cell expert E. John Wherry, PhD CAMBRIDGE, Mass., March 20,…